168 related articles for article (PubMed ID: 32209667)
1. Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicity.
Kumar S; Singh SK; Viswakarma N; Sondarva G; Nair RS; Sethupathi P; Sinha SC; Emmadi R; Hoskins K; Danciu O; Thatcher GRJ; Rana B; Rana A
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7961-7970. PubMed ID: 32209667
[TBL] [Abstract][Full Text] [Related]
2. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8
Kumar S; Singh SK; Viswakarma N; Sondarva G; Nair RS; Sethupathi P; Dorman M; Sinha SC; Hoskins K; Thatcher G; Rana B; Rana A
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32759234
[TBL] [Abstract][Full Text] [Related]
3. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
4. MLK3 mediates impact of PKG1α on cardiac function and controls blood pressure through separate mechanisms.
Calamaras TD; Pande S; Baumgartner RA; Kim SK; McCarthy JC; Martin GL; Tam K; McLaughlin AL; Wang GR; Aronovitz MJ; Lin W; Aguirre JI; Baca P; Liu P; Richards DA; Davis RJ; Karas RH; Jaffe IZ; Blanton RM
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34324442
[TBL] [Abstract][Full Text] [Related]
5. MLK3 regulates fMLP-stimulated neutrophil motility.
Polesskaya O; Wong C; Lebron L; Chamberlain JM; Gelbard HA; Goodfellow V; Kim M; Daiss JL; Dewhurst S
Mol Immunol; 2014 Apr; 58(2):214-22. PubMed ID: 24389043
[TBL] [Abstract][Full Text] [Related]
6. Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1.
Das S; Nair RS; Mishra R; Sondarva G; Viswakarma N; Abdelkarim H; Gaponenko V; Rana B; Rana A
Oncogene; 2019 May; 38(19):3569-3584. PubMed ID: 30664689
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic inhibition of MLK3 kinase activity blocks the in vitro migratory capacity of breast cancer cells but has no effect on breast cancer brain metastasis in a mouse xenograft model.
Rhoo KH; Granger M; Sur J; Feng C; Gelbard HA; Dewhurst S; Polesskaya O
PLoS One; 2014; 9(9):e108487. PubMed ID: 25264786
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function.
Pellom ST; Dudimah DF; Thounaojam MC; Uzhachenko RV; Singhal A; Richmond A; Shanker A
Oncotarget; 2017 Jan; 8(5):8604-8621. PubMed ID: 28052005
[TBL] [Abstract][Full Text] [Related]
9. Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer development.
Viswakarma N; Sondarva G; Principe DR; Nair RS; Kumar S; Singh SK; Das S; Sinha SC; Grippo PJ; Grimaldo S; Giulianotti PC; Rana B; Rana A
Cancer Lett; 2021 Sep; 515():1-13. PubMed ID: 34052323
[TBL] [Abstract][Full Text] [Related]
10. Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival.
Das S; Sondarva G; Viswakarma N; Nair RS; Osipo C; Tzivion G; Rana B; Rana A
J Biol Chem; 2015 Aug; 290(35):21705-12. PubMed ID: 26152725
[TBL] [Abstract][Full Text] [Related]
11. Estrogen suppresses MLK3-mediated apoptosis sensitivity in ER+ breast cancer cells.
Rangasamy V; Mishra R; Mehrotra S; Sondarva G; Ray RS; Rao A; Chatterjee M; Rana B; Rana A
Cancer Res; 2010 Feb; 70(4):1731-40. PubMed ID: 20145118
[TBL] [Abstract][Full Text] [Related]
12. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
Chen J; Miller EM; Gallo KA
Oncogene; 2010 Aug; 29(31):4399-411. PubMed ID: 20514022
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis.
Viswakarma N; Nair RS; Sondarva G; Das S; Ibrahimi L; Chen Z; Sinha S; Rana B; Rana A
Oncotarget; 2017 May; 8(20):33172-33184. PubMed ID: 28388540
[TBL] [Abstract][Full Text] [Related]
14. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
15. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
Yin W; Song Y; Liu Q; Wu Y; He R
Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
[TBL] [Abstract][Full Text] [Related]
16. MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis.
Chen J; Gallo KA
Cancer Res; 2012 Aug; 72(16):4130-40. PubMed ID: 22700880
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3.
Mishra R; Barthwal MK; Sondarva G; Rana B; Wong L; Chatterjee M; Woodgett JR; Rana A
J Biol Chem; 2007 Oct; 282(42):30393-405. PubMed ID: 17711861
[TBL] [Abstract][Full Text] [Related]
18. Mixed lineage kinase-3/JNK1 axis promotes migration of human gastric cancer cells following gastrin stimulation.
Mishra P; Senthivinayagam S; Rangasamy V; Sondarva G; Rana B
Mol Endocrinol; 2010 Mar; 24(3):598-607. PubMed ID: 20150185
[TBL] [Abstract][Full Text] [Related]
19. Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity.
Sharma M; Gadang V; Jaeschke A
Mol Pharmacol; 2012 Nov; 82(5):1001-7. PubMed ID: 22918968
[TBL] [Abstract][Full Text] [Related]
20. NFATc1 Promotes Antitumoral Effector Functions and Memory CD8
Heim L; Friedrich J; Engelhardt M; Trufa DI; Geppert CI; Rieker RJ; Sirbu H; Finotto S
Cancer Res; 2018 Jul; 78(13):3619-3633. PubMed ID: 29691251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
